Shelton, CT, United States of America

Wolfgang Barth

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang Barth. Retrieved from https://idiyas.com/inventor/wolfgang-barth-2yrvbys6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Wolfgang Barth in Nasal Administration

Introduction

Wolfgang Barth is an accomplished inventor based in Shelton, CT (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of nasal administration. His innovative work has led to the development of a unique patent that addresses important medical needs.

Latest Patents

Wolfgang Barth holds a patent for "Imidazotriazinone-containing compositions for nasal administration." This invention relates to compositions that not only include a cGMP PDE inhibitor but also a small amount of a local anesthetic. This combination aims to enhance the efficacy and comfort of nasal treatments.

Career Highlights

Barth is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on developing innovative solutions that improve patient care and treatment outcomes.

Collaborations

Throughout his career, Wolfgang Barth has collaborated with notable colleagues, including Peter Serno and Hans-Martin Siefert. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Wolfgang Barth's contributions to nasal administration through his patented compositions demonstrate his commitment to advancing medical science. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…